Humira, which is used to treat rheumatoid arthritis, psoriatic
arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis and psoriasis, accounts for nearly $20B in global sales.
According to the ministry, the company updated the list of side effects caused by the two medicines used for treating rheumatoid arthritis, Psoriatic
arthritis and Ulcerative colitis.
Chronic inflammation has been implicated in a range of diseases, including rheumatoid arthritis, psoriatic
arthritis, lupus, inflammatory bowel disease, Crohn's Disease, Psoriasis, Liver Disease and certain forms of cancer.
Founded in 1987, Colorado Arthritis Center specializes in the diagnosis and treatment of a wide range of autoimmune and inflammatory diseases including rheumatoid arthritis, psoriatic
arthritis, lupus, vasculitis, and many other conditions.
The Department of Rheumatology at HMC receives hundreds of cases associated with autoimmune disorders such as rheumatoid arthritis, psoriatic
arthritis, spondylococcal spondylitis, and other diseases caused by an autoimmune dysfunction that makes it attack the cells of the body itself, as strange cells.
A biologic drug, Enbrel is indicated for the treatment of several chronic conditions, including moderate-to-severe rheumatoid arthritis, moderate-to-severe polyarticular juvenile idiopathic arthritis, psoriatic
arthritis, ankylosing spondylitis and moderate-to-severe plaque psoriasis.
In the European Union, the product recently received positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for multiple chronic inflammatory diseases including, in adults with moderate to severely active rheumatoid arthritis, Psoriatic
arthritis, moderate to severely active Crohn's disease, severe active ankylosing spondylitis, moderate to severely active ulcerative colitis, severe axial spondyloarthritis without radiographic evidence of AS, moderate to severe chronic plaque psoriasis, moderate to severe hidradenitis suppurativa and non-infectious intermediate, posterior and panuveitis.
Total spending per person with employer-sponsored insurance was $45.11 last year for Humira Pen, which is indicated for rheumatoid arthritis, psoriatic
arthritis, anky-losing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.
to provide fill-finish production services for the commercial supply of SB4, a biosimilar referencing Enbrel (etanercept), which is used to treat rheumatoid arthritis, psoriatic
arthritis, axial spondyloarthritis and plaque psoriasis.
These inhibitors are used to manage diseases like rheumatoid arthritis, psoriatic
arthritis, psoriasis, inflammatory bowel disease, and seronegative spondyloarthropathies.